Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237545 · ClinicalTrials.gov registry record · NA
A Clinical Study of the T3 Short Dental Implant System
A NA study of Edentulous Jaw, sponsored by ZimVie.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 4
- Study locations
NCT04237545: Completed NA study of Edentulous Jaw, sponsored by ZimVie.
NCT04237545 is a NA study of Edentulous Jaw that has completed, run by ZimVie. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04237545, a NA study of Edentulous Jaw, has completed, sponsored by ZimVie.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 4
- Study locations
Study Summary
This clinical study will evaluate the safety and performance of the T3 short dental implant when placed in the posterior maxilla and mandible.
Primary Outcome
Assess and compare peri-implant crestal bone level changes between test and control device from baseline to 4 years
Conditions Studied
Interventions
- DEVICE T3 short and restoration (prosthesis)
- DEVICE T3 standard length and restoration (prosthesis)
Study Locations (4)
Massachusetts
- Dr. Xiaozhe Han - Boston
Michigan
- Dr. Suheil Boutros - Dearborn Heights
Other
- Dr. Stefano Sivolella - Padua
Catalonia
- Dr. Jordi Gargallo - Tarragona
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the finished NCT04237545 record still lists
NCT04237545 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Edentulous Jaw appearing as the primary indexed condition, and to 2 interventions - of which T3 short and restoration (prosthesis) is the first listed.
NCT04237545 reports a single indexed study location in Massachusetts, Michigan, Other.
Frequently Asked Questions
What is clinical trial NCT04237545 about?
NCT04237545 is a clinical study titled "A Clinical Study of the T3 Short Dental Implant System". This clinical study will evaluate the safety and performance of the T3 short dental implant when placed in the posterior maxilla and mandible.
What is the current status of trial NCT04237545?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2019-10-01. Estimated completion is 2026-01-31.
What conditions does trial NCT04237545 study?
This clinical trial studies the following conditions: Edentulous Jaw.
What interventions are being tested in trial NCT04237545?
The interventions under investigation include: T3 short and restoration (prosthesis) (DEVICE), T3 standard length and restoration (prosthesis) (DEVICE).
Who is sponsoring clinical trial NCT04237545?
This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04237545 being conducted?
This trial has 4 study locations across Massachusetts, Michigan, Catalonia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Edentulous Jaw
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04237545's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI